Literature DB >> 29990829

RETRACTED: Astragaloside IV reduces the hypoxia-induced injury in PC-12 cells by inhibiting expression of miR-124.

Wei Yu1, Zaigang Lv2, Ligong Zhang2, Zongen Gao2, Xiaohui Chen2, Xirui Yang3, Mengfei Zhong4.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Astragaloside IV; Hic-5; Hypoxia injury; Sp1/Survivin pathway; miR-124

Mesh：

Substances：

Year:  2018        PMID： 29990829     DOI： 10.1016/j.biopha.2018.06.127

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  7 in total

1.  Astragaloside IV and echinacoside benefit neuronal properties via direct effects and through upregulation of SOD1 astrocyte function in vitro.

Authors:  Yang Tian; Shijie Jin; Vanessa Promes; Xuemei Liu; Yunling Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-20       Impact factor: 3.000

2.  Preliminary study on the anti-apoptotic mechanism of Astragaloside IV on radiation-induced brain cells.

Authors:  Xin Liu; Weiwei Chu; Shuying Shang; Liang Ma; Chenxin Jiang; Yanping Ding; Jianlin Wang; Shengxiang Zhang; Baoping Shao
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

3.  Proapoptotic effects of 2,5‑hexanedione on pheochromocytoma cells via oxidative injury.

Authors:  Baoning Qi; Shouzhu Xu; Yuan Liang; Jiaxin Wang; Zhigang Zhang; Juan Li; Jing Zhou
Journal:  Mol Med Rep       Date:  2019-08-01       Impact factor: 2.952

4.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

5.  Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress.

Authors:  Yu Fu; Jianhang Cai; Mengyao Xi; Yifei He; Yang Zhao; Yi Zheng; Yidong Zhang; Jinkun Xi; Yonggui He
Journal:  Oxid Med Cell Longev       Date:  2020-12-31       Impact factor: 6.543

6.  Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication.

Authors:  Gyeong-Seok Lee; Hee-Yeon Jeong; Hyeon-Gung Yang; Young-Ran Seo; Eui-Gil Jung; Yong-Seok Lee; Kung-Woo Nam; Wan-Jong Kim
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

7.  Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88.

Authors:  Dexin Li; Guangcheng Li; Yang Chen; Yifei Li; Junfeng Zhang; Dexuan Gao; Linglong Sun; Bo Liu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.